Z-1349-2020 Class II Terminated

Recalled by Randox Laboratories, Limited — Crumlin, N/A

FDA device recall Z-1349-2020 was initiated by Randox Laboratories, Limited on Dec 19, 2019 and is designated Class II. Reason for recall: Software version UI2550642107 for the RX Daytona + instrument released to correct the following issues: 1) The order of samples displayed is not sequential according to SID (sample identification… The recall status is terminated (terminated Apr 23, 2021). Affected quantity: U.S.: RX4040-2 units RX 4041-3 units.

Recall details

Product Type
Devices
Report Date
Mar 4, 2020
Initiation Date
Dec 19, 2019
Termination Date
Apr 23, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
U.S.: RX4040-2 units RX 4041-3 units

Product description

RX Daytona Plus (with ISE/without ISE); Models Nos. RX4040 (w/ISE) and RX4041 (without ISE) - Product Usage: A fully automated, random access, clinical chemistry analyzer complete with dedicated analyzer software. For use in clinical laboratories.

Reason for recall

Software version UI2550642107 for the RX Daytona + instrument released to correct the following issues: 1) The order of samples displayed is not sequential according to SID (sample identification number) when searching the run/results screen; 2) Incorrect color flagging of IQC as "out of range."

Distribution pattern

US Nationwide distribution including state of PR.

Code information

Software version UI2550642107 for the RX Daytona Plus instrument.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1349-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1349-2020. Report a data issue: hello@regdatalab.com.